Ellis Investment Partners’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-700
| Closed | -$6K | – | 290 |
|
|
2022
Q3 | $6K | Hold |
700
| – | – | ﹤0.01% | 639 |
|
|
2022
Q2 | $5K | Hold |
700
| – | – | ﹤0.01% | 669 |
|
|
2022
Q1 | $9K | Hold |
700
| – | – | ﹤0.01% | 628 |
|
|
2021
Q4 | $11K | Hold |
700
| – | – | ﹤0.01% | 607 |
|
|
2021
Q3 | $11K | Hold |
700
| – | – | ﹤0.01% | 590 |
|
|
2021
Q2 | $9K | Hold |
700
| – | – | ﹤0.01% | 619 |
|
|
2021
Q1 | $10K | Hold |
700
| – | – | ﹤0.01% | 575 |
|
|
2020
Q4 | $12K | Hold |
700
| – | – | ﹤0.01% | 538 |
|
|
2020
Q3 | $12K | Sell |
700
-300
| -30% | -$5.14K | ﹤0.01% | 536 |
|
|
2020
Q2 | $18K | Hold |
1,000
| – | – | 0.01% | 466 |
|
|
2020
Q1 | $15K | Hold |
1,000
| – | – | 0.01% | 430 |
|
|
2019
Q4 | $18K | Hold |
1,000
| – | – | 0.01% | 445 |
|
|
2019
Q3 | $19K | Hold |
1,000
| – | – | 0.01% | 449 |
|
|
2019
Q2 | $22K | Buy |
+1,000
| New | +$22K | 0.01% | 425 |
|